Scientists at the Icahn School of Medicine at Mount Sinai have developed a lipid nanoparticle system capable of delivering messenger RNA (mRNA) to the brain via intravenous injection — a challenge ...

UCLA researchers have developed a nanoparticle that carries a combination treatment with an mRNA vaccine and a small immune-boosting ... The nanoparticles are made of lipids, similar to the waxy ...

Reference: Xu X, Wang X, Liao YP, Luo L, Nel AE. Reprogramming the tolerogenic immune response against pancreatic cancer metastases by lipid nanoparticles delivering a STING agonist plus mutant KRAS ...

Objective This study aimed to establish HAV and HEV infections in multiple small animals by intravenously injecting lipid nanoparticle (LNP)-encapsulated full-length viral RNAs (LNP-vRNA). Design In ...

More information: Xiao Xu et al, Reprogramming the Tolerogenic Immune Response Against Pancreatic Cancer Metastases by Lipid Nanoparticles Delivering a STING Agonist Plus Mutant KRAS mRNA ...

The recent success of the mRNA-LNP vaccines fueled biopharma to explore lipid-based nanoparticles for advanced drug delivery. The industry is now poised to exploit the full therapeutic potential ...

"In the years that followed, physicians at the Clinic for Special Children worked intently with scientists and veterinarians from UMass Chan Medical School to achieve that goal, drawing their ...

RIBOPRO is a Netherlands-based technology and service provider specializing in mRNA and lipid nanoparticle (LNP) technologies. Founded in 2020, RIBOPRO develops and manufactures high-quality mRNA ...